Cambridge Nutrition. - Updated Notice of AGM

Cambridge Nutritional Sciences

11/09/2026 14:13

RNS Number : 4852U
  
Cambridge Nutritional Sciences PLC
  
11 September 2026
  
 



11 September 2026


Cambridge Nutritional Sciences plc


 


(the "Company" or "CNSL")


 


Updated Notice of AGM and Annual Report to 31 March 2026


 


Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms that the Notice of Annual General Meeting ('AGM') has been rescheduled and finalised for the year ended 31 March 2026. The Company's AGM will be held on Wednesday 28 October 2026 at 2.00pm at E-space North, 181 Wisbech, Littleport, Ely, CB6 1RA. This update is to ensure the statutory 21 days’ clear notice between the results/hard copy annual report receipt and AGM is provided.


 


The Annual Report for the year ended 31 March 2026 is available on the Company's website at:


 


https://www.cnsplc.com/financials/  


 


and includes all the Notice of AGM details on pages 81-87. Formal notices will be sent to all shareholders in the next few weeks.


 


 


Contacts: 



Cambridge Nutritional Sciences plc         




www.cnsplc.com




Carolyn Rand, Non-Executive Chair




investors@cnsplc.com




James Cooper, Chief Executive Officer




 




Ajay Patel, Chief Financial Officer




 




 


Cavendish Capital Markets Limited     




 


Tel: 020 7220 0500




Geoff Nash / Edward Whiley / (Corporate Finance)




 




Nigel Birks / Harriet Ward (ECM)




 




 




 




 




 









About Cambridge Nutritional Sciences plc


Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.


 


 



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NOAUAAORNRUKAAR